1 / 69

The Single Ventricle

The Single Ventricle. Karim Rafaat, M.D. The title “ single ventricle ” includes those lesions designated as both HLHS HRHS HLHS is far more common, and the strategy for palliation of both lesions similar, so I will not mention HRHS. HLHS - History.

graham
Download Presentation

The Single Ventricle

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Single Ventricle Karim Rafaat, M.D.

  2. The title “single ventricle” includes those lesions designated as both • HLHS • HRHS • HLHS is far more common, and the strategy for palliation of both lesions similar, so I will not mention HRHS

  3. HLHS - History • First described in 1952 by Lev as the pathologic complex “hypoplasia of the aortic tract”,included cases of: • hypoplasia of the aorta and VSD • hypoplasia of the aorta with aortic stenosis or atresia, with or without mitral stenosis or atresia • In 1958, Noonan and Nadas termed these lesions as “hypoplastic left heart syndrome”.

  4. Embryology • The embryologic cause is not fully understood. • It probably results from a limitation of either LV inflow or outflow, such as the development of severe AS early • Decreased antegrade flow through LV • most common cause is mitral atresia • decreased division of cardiac myocytes

  5. Genetics • Familial inheritance: • Autosomal recessive and multifactorial inheritance have both been postulated. • Sibling recurrence risk: 0.5% • Sibling recurrence for all other cardiac malformations: 2.2% • Definable genetic disorder (28%): • Turner Syndrome • Noonan Syndrome • Trisomy 13, 18, 21, or other microdeletion syndromes

  6. Epidemiology • Uniformly lethal prior to 1980 • Each year, approximately 1000 infants with HLHS are born in the US. • Prevalence: 1 per 6000-7000 live births. • In pathologic series, it accounts for 1.4-3.8% of congenital heart disease. • Third most common cause of critical CHD in the newborn. • 23% of all neonatal mortality from CHD • Male predominance: 57-70%.

  7. Anatomy • Underdevelopment of the left side of the heart • atresia of the aortic or mitral orifice • hypoplasia of the ascending aorta. • The left ventricle may be small and nonfunctional or totally atretic

  8. Pulmonary venous return from LA to RA through a large PFO or ASD • Systemic venous blood mixes with pulmonary venous blood in the RA and RV • RV ejects blood into a large MPA

  9. Systemic circulation is supplied in parallel with pulmonary circulation through a PDA • Multiple obstructions to systemic flow • Aortic valve atresia • Arch hypoplasia • Place systemic flow at risk

  10. Blood flow to the coronary and cerebral circulations is retrograde • Usually little or no flow through aortic valve • Postnatal decline in PVR • places systemic, and especially the ductal dependant and retrogradely supplied coronary and cerebral vascular beds at risk for hypoperfusion secondary to pulmonary run-off

  11. Pathophysiology • Relative Qp and Qs determined via resistances of respective vascular beds • Ventricle must supply both Qp and Qs • Single right ventricle has at least twice the volume load of an in series ventricle • Significantly volume overloaded

  12. The aim of initial management is to optimize Qp and Qs in a manner that provides adequate end organ oxygen delivery without overloading the single ventricle • Remember my last lecture? • This balancing act is only temporizing and serves to allow pt to survive to definitive treatment

  13. Treatment options • Supportive care • Only option up to 25 years ago • Is still main option of treatment in many countries • Staged reconstruction • Stage I Norwood Procedure • Stage II Bi-directional Glenn or Hemi-Fontan • Stage III Fontan Procedure • Transplant

  14. Goals of Surgery • Unobstructed systemic blood flow • To maximize oxygen delivery and minimize ventricular hypertrophy • Limited pulmonary blood flow • To minimize ventricular volume load and the risk of pulmonary hypertension • Unobstructed pulmonary venous return • To minimize secondary pulmonary artery hypertension • Minimize likelihood of pulmonary artery distortion • Avoid dysrhythmias

  15. All these goals, achieved in a timely fashion, circumvent the major risk factors for poor outcome post-Fontan: • Ventricular hypertrophy causing diastolic dysfunction • Elevated PVR or pulmonary artery pressure • AV valve regurgitation • Ventricular systolic dysfunction • The reasons why the above hurt the post-fontan heart will be discussed later

  16. Stage I – Norwood palliation • The goal of the Norwood is to stabilize and balance the parallel circuit, protect the pulmonary vascular bed and preserve ventricular function • Adequate oxygen delivery allows for the growth necessary for a hemi-fontan or BDG to be performed

  17. Native ascending and transverse aortic arch is incorporated into a neo-aorta • Neo-aorta created by augmenting native arch with autologous pulmonary homograft • Neo-aorta is attached to the proximal pulmonary artery trunk • Neo-aorta provides systemic outflow • Important that the neo-aorta is free of obstruction • Obstruction is poorly tolerated by the single ventricle and is associated with increased interstage mortality

  18. Distal MPA is closed • Pulmonary flow is provided by a restrictive shunt from the right innominate artery to the RPA • Modified BTS

  19. Post-Norwood Anatomy

  20. Post-Norwood issues • The hope is that now • RBTS + Rp = Rs • So the circulations are balanced and volume work is minimized • Meaning for a given required Qs, total Q can be less as the ratio is more favorable • But……

  21. The ventricle has just been through hypothermic cardiopulmonary bypass with myocardial ischemia/arrest • Vascular endothelium of the systemic and pulmonary circulations have also been subjected to bypass and injury • Combined effect is a systemic inflammatory and adrenergic stress response • The ventricle can also exhibit a low cardiac output syndrome in the first 12-24 hours post op

  22. All vascular beds show signs of endothelial dysfunction • Evidenced by increased resistance • This may tip the balance of flow towards the pulmonary circulation • Systemic oxygen demands may be unable to be met by the post-op ventricle • Leading to anaerobic metabolism, acidosis and worsening function • LCOS

  23. Low Cardiac Output • Low systemic cardiac output can be due to • Globally decreased ventricular function • Elevated Qp:Qs • AV valve regurgitation • How to discern between the above?

  24. Echocardiography • Evaluates pump function and rules out AV valve regurg • Arterial-venous oxygen saturation difference • An A-V DO2 more than 40% suggests inadequate tissue delivery of oxygen and low systemic cardiac output • OR…Lactate level plus base deficit • Good echo function plus high A-V DO2 = Qp>Qs

  25. Treatment • One must pay attention to both TOTAL CO and the Qp:Qs ratio • The ratio can be altered by maneuvers discussed in my last talk • Total CO can be increased by careful selection of vasoactive agents • Want to avoid tachycardia and increasing afterload • Milrinone • Nesiritide • Dopamine

  26. Hypoxemia • Pulmonary Venous desaturation • Atelectasis • pulmonary edema • pneumothorax • Systemic venous desaturation • Anemia • Low cardiac output • Decreased pulmonary blood flow • Elevated PVR • Pulmonary venous hypertension • Pulmonary artery distortion • Restrictive systemic to pulmonary shunt • Gotta rule out the top two, then, think about echo or cath to rule out the anatomic causes • Which need a surgeon….

  27. Coronary circulation • Single right ventricle coronary blood flow occurs predominantly in diastole • Like an in series LV • When pulmonary flow is supplied by a shunt from a systemic artery, increases in SVR lead to increased pulmonary flow, and increased diastolic pulmonary run-off • This can lead to myocardial ischemia….and sudden death • Which is why

  28. Dr. Cocalis The Wall of Wo “Leaving a kid in Norwood physiology is like taking a walk through Watts at midnight”

  29. Sudden death post Norwood • Unpredictable and sudden • Experienced centers report survival between 63-94%1 • Inter-stage mortality of 10-15%2 • Rapid fall in PVR, or increase in SVR • Steal from coronary arteries • lower pressure in pulmonary circulation throughout cardiac cycle The Journal of Thoracic and Cardiovascular Surgery 2003;126(2) 504-509 Arch Dis Child Fetal Neonatal Ed 2005;90:F97-102.

  30. Bartram et al, Causes of Death after the Modified Norwood procedure: A study of 122 postmortem cases, Ann Thorac Surg, 1997 • 122 cases over 15 years • The leading causes of death • largely correctable surgical technical problems associated with perfusion of the lungs (36%), of the myocardium (27%), and of the systemic organs (14%).

  31. The proposed solution to • surgical manipulation of the coronary arteries • the pulmonary diastolic run-off through the modified BTS • Is an RV to PA conduit • First described by Norwood in 1981 • Reintroduced by Japanese surgeon Sano in the late 1990’s

  32. The Sano modification • Directly supplies pulmonary flow via the RV • Aortic diastolic runoff does not occur • Post-op diastolic BP is higher • Coronary perfusion is improved • Blood flows only during systole • Reducing total pulmonary blood flow • Improves Qp:Qs, thus protecting pulmonary vascular bed and decreases volume load on the RV, giving it a greater chance to return to normal size and function

  33. Less distortion of the pulmonary arteries than is seen with a BTS • Improved growth of PA’s

  34. Trade off’s • Ventriculotomy • Increases potential for low cardiac output syndrome • The damage to the ventricular wall may be offset by the better coronary perfusion….. • Increased volume load secondary to reversed diastolic flow in a non-valved conduit • Possibility of shunt occlusion • Concern of RV arrhythmias post ventriculotomy • Not confirmed by present studies, though

  35. Januszewska et al, RV to PA shunt and modified BTS in preparation for hemi-Fontan procedure in children with HLHS, European Jour Cardiac Surg, 27, 2005 • 78 children – 27 underwent Norwood with BTS 51 underwent Sano modification • Those who underwent Sano, at time of hemi-fontan • Larger pulmonary arteries • Which means lower resistance to the passive flow that will be supplying the lungs after the BDG or Fontan • Less RVH • Better diastolic function, and so lower filling pressures required • Lower Qp:Qs (0.8 vs 1.27) • Less pulmonary vascular remodeling and less ventricular volume load

  36. Pizzaro et al, Right Ventricle to Pulmonary Artery Conduit Improves Outcome after stage I Norwood for HLHS, Circulation, 2003; 108 • Retrospective cohort review • 36 RV to PA conduits • 20 BTS • Those with RV to PA conduits • Higher diastolic BP • Lower PaO2 • Indicating lower Qp:Qs secondary to less diastolic run-off • Less ventilatory manipulations were required for Qp:Qs management • 33/36 survived to BDG vs 14/20 in the BTS group

  37. Other Considerations • Risk for shunt occlusion • Low sats lead to high Hct’s, which increases risk of thromboembolic complications • Need to be well hydrated • Shunt failure • Slowly occurs as pt grows, but shunt does not • Leads to slowly progessive cyanosis as oxygen consumption increases in a growing pt • VENOUS ACCESS • Any venous embolus may reach systemic vascular beds • Watch for air bubbles, clots, meticulously….

  38. Glenn Hughes – A Village Person Bidirectional?

  39. Stage II – Partial Cavopulmonary Anastomosis • After stage I, there are two problems • Cyanosis • Excessive ventricular volume load • The Fontan fixes both of the above, but must come after an intermediate step… • Why?

  40. Reasons for a staged repair • The fontan requires low PVR to allow for passive pulmonary flow • PVR does not reach nadir until 6-8 months • Furthermore, following the high Qp:Qs state of pre-norwood, the pulmonary vasculature can be reactive • Which is exacerbated by the stress of bypass

  41. The parallel circulation single ventricle is relatively hypertrophied and dilated secondary to volume overload • Shifts Frank-Starling curve down and to the right • Means the norwood ventricle is very volume sensitive • A loss of ventricular filling secondary to increases in PVR would lead to critically decreased CO

  42. The solution is a staged procedure that allows for more gradual ventricular unloading and remodeling • Also allows for adjustment of the upper body venous and lymphatic systems to deal with an increase in venous pressure prior to the Fontan • Usually performed around 4-6 months of age

  43. Bidirectional Glenn • The RV/PA or BT shunt is removed • This volume unloads the ventricle • Critical in improving outcome in single ventricle palliation • SVC is anastomosed end to side with the RPA • Is more compatible with an extracardiac fontan procedure down the line

  44. Hemi-Fontan • Similar to BDG physiologically • Has additional proximal SVC and inferior RPA anastomosis • RA communication closed with a patch • More suited for eventual lateral baffle Fontan

  45. Stage II Physiology • Half the blood to the heart comes from the IVC, half from the pulmonary veins • Qp:Qs is now 0.5 • SaO2 about 75-85% • Infants with bigger heads have higher sats • Excessive volume load is now eliminated • Ventricle now pumps only Qs • Decreased cavity dimension and increased wall thickness improves tricuspid function

  46. Preload is not critically dependant upon unimpeded pulmonary flow • Increases in PVR won’t significantly affect systemic circulation • Qp driving force is now SVC pressure • Qp must pass through two highly regulated vascular beds • Pulmonary and cerebral

  47. Transpulmonary pressure gradient • Mean pulmonary arterial pressure – mean atrial pressure • Represents the driving force through the lungs • Low PVR allows for a low delta P • Which means lower SVC pressures

  48. Pulmonary flow can be impaired by • High PVR • Increased atrial pressures • AV valve dysfunction • Ventricular diastolic dysfunction • A low transpulmonary gradient with a good CO means good things for sleep….

  49. Post-Op issues – Ventilator Management • Excessive Paw • will limit systemic venous return via increased intrathoracic pressure • increase PVR, potentially decreasing pulmonary flow AND increases SVC pressure • Minimize iT, PIP and choose PEEP that allows for maintenance of FRC • Remember that Qp comes through the cerebral vascular bed… • So maneuvers like alkalosis and hyperventilation to decrease PVR may INCREASE cerebral vasc resistance, decreasing flow and further exacerbate hypoxemia

More Related